High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions-Reference-Cited by-同舟云学术

High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions

Published:2020-09-25 Issue:2 Volume:14 Page:241-248
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Maurino Jorge^ORCID,Sotoca Javier,Sempere Ángel P.,Brieva Luis,López de Silanes Carlos,Caminero Ana B.,Terzaghi María,Gracia-Gil Julia,Saposnik Gustavo

Funder

Roche Spain

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40271-020-00454-3.pdf

Reference39 articles.

1. Dobson R, Giovannoni G. Multiple sclerosis—a review. Eur J Neurol. 2019;26(1):27–40.

2. Timmermans ST, de Groot V, Beckerman H. Ten-year disease progression in multiple sclerosis: walking declines more rapidly than arm and hand function. Mult Scler Relat Disord. 2020;45:102343.

3. García-Domínguez JM, Maurino J, Martínez-Ginés ML, et al. Economic burden of multiple sclerosis in a population with low physical disability. BMC Public Health. 2019;19(1):609.

4. Li H, Hu F, Zhang Y, Li K. Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis. J Neurol. 2019. https://doi.org/10.1007/s00415-019-09395-w(Online ahead of print).

5. Stankiewicz JM, Weiner HL. An argument for broad use of high efficacy treatments in early multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2019;7:e636.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-11

2. Quality of reporting health behaviors for multiple sclerosis (QuoRH‐MS): A scoping review to inform intervention planning and improve consistency of reporting;Brain and Behavior;2024-08

3. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis;Patient Preference and Adherence;2024-06

4. A systematic review to explore patients’ MS knowledge and MS risk knowledge;Neurological Sciences;2024-05-03

5. Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN);Neurological Sciences;2024-05-03